Avadel Pharmaceuticals (AVDL) PT Lowered to $10 at Ladenburg Thalmann

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. CPAY

Go back to Avadel Pharmaceuticals (AVDL) PT Lowered to $10 at Ladenburg Thalmann

Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results

November 5, 2018 8:01 AM EST

DUBLIN, Ireland, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, today announced its financial results for the third quarter of 2018.

Mike Anderson, Avadels Chief Executive Officer, said, We executed a number of important initiatives during the third quarter related to our REST-ON Phase 3 FT 218 clinical study in narcolepsy and our recently launched product, NOCTIVA. For REST-ON, we completed 10 new clinical site initiations, hosted two successful patient events with well over 100... More